<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38622757</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2150-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Virulence</Title><ISOAbbreviation>Virulence</ISOAbbreviation></Journal><ArticleTitle>The multiple roles of viral 3D<sup>pol</sup> protein in picornavirus infections.</ArticleTitle><Pagination><StartPage>2333562</StartPage><MedlinePgn>2333562</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2333562</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/21505594.2024.2333562</ELocationID><Abstract><AbstractText>The <i>Picornaviridae</i> are a large group of positive-sense, single-stranded RNA viruses, and most research has focused on the Enterovirus genus, given they present a severe health risk to humans. Other picornaviruses, such as foot-and-mouth disease virus (FMDV) and senecavirus A (SVA), affect agricultural production with high animal mortality to cause huge economic losses. The 3D<sup>pol</sup> protein of picornaviruses is widely known to be used for genome replication; however, a growing number of studies have demonstrated its non-polymerase roles, including modulation of host cell biological processes, viral replication complex assembly and localization, autophagy, and innate immune responses. Currently, there is no effective vaccine to control picornavirus diseases widely, and clinical therapeutic strategies have limited efficiency in combating infections. Many efforts have been made to develop different types of drugs to prohibit virus survival; the most important target for drug development is the virus polymerase, a necessary element for virus replication. For picornaviruses, there are also active efforts in targeted 3D<sup>pol</sup> drug development. This paper reviews the interaction of 3D<sup>pol</sup> proteins with the host and the progress of drug development targeting 3D<sup>pol</sup>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Fengge</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Haixue</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3979-8991</Identifier><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virulence</MedlineTA><NlmUniqueID>101531386</NlmUniqueID><ISSNLinking>2150-5594</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015684">Gene Products, pol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015684" MajorTopicYN="N">Gene Products, pol</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029544" MajorTopicYN="Y">Foot-and-Mouth Disease Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3Dpol</Keyword><Keyword MajorTopicYN="N">Picornaviruses</Keyword><Keyword MajorTopicYN="N">RNA-dependent RNA polymerase</Keyword><Keyword MajorTopicYN="N">RdRp inhibitor</Keyword><Keyword MajorTopicYN="N">virus-host interaction</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>16</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>23</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38622757</ArticleId><ArticleId IdType="pmc">PMC11020597</ArticleId><ArticleId IdType="doi">10.1080/21505594.2024.2333562</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778–18. doi: 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, et al. ICTV virus taxonomy profile: Picornaviridae. J Gen Virol. 2017;98(10):2421–2422. doi: 10.1099/jgv.0.000911</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000911</ArticleId><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P, Ji W, Li D, et al. Current status of hand-foot-and-mouth disease. J Biomed Sci. 2023;30(1):15. doi: 10.1186/s12929-023-00908-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-023-00908-4</ArticleId><ArticleId IdType="pmc">PMC9951172</ArticleId><ArticleId IdType="pubmed">36829162</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Li Y, Yin Q, et al. Coxsackievirus A6 pneumonia in a child. Lancet Infect Dis. 2023;23(12):e567. doi: 10.1016/S1473-3099(23)00576-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00576-5</ArticleId><ArticleId IdType="pubmed">38000879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J, Xu D, Yang C, et al. Severe pneumonia and pathogenic damage in human airway epithelium caused by coxsackievirus B4. Emerg Microbes Infect. 2023;12(2):2261560. doi: 10.1080/22221751.2023.2261560</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2261560</ArticleId><ArticleId IdType="pmc">PMC10538465</ArticleId><ArticleId IdType="pubmed">37725516</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X-S, Ong JJ, Macgregor L, et al. Transmission dynamics of the 2016-18 outbreak of hepatitis a among men who have sex with men in England and cost-effectiveness analysis of vaccination strategies to prevent future outbreaks. Lancet Reg Health Eur. 2022;19:100426. doi: 10.1016/j.lanepe.2022.100426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100426</ArticleId><ArticleId IdType="pmc">PMC9417902</ArticleId><ArticleId IdType="pubmed">36039276</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Santisteve P, Tavoschi L, Severi E, et al. Seroprevalence and susceptibility to hepatitis a in the European Union and European Economic Area: a systematic review. Lancet Infect Dis. 2017;17(10):e306–e319. doi: 10.1016/S1473-3099(17)30392-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30392-4</ArticleId><ArticleId IdType="pubmed">28645862</ArticleId></ArticleIdList></Reference><Reference><Citation>Tambyah PA, Oon J, Asli R, et al. An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: a phase I, double blind, randomized, placebo-controlled, study of two dosages. Vaccine. 2019;37(31):4344–4353. doi: 10.1016/j.vaccine.2019.06.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.06.023</ArticleId><ArticleId IdType="pubmed">31230881</ArticleId></ArticleIdList></Reference><Reference><Citation>di Nardo A, Ferretti L, Wadsworth J, et al. Evolutionary and ecological drivers shape the emergence and extinction of foot-and-mouth disease virus lineages. Mol Biol Evol. 2021;38(10):4346–4361. doi: 10.1093/molbev/msab172</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msab172</ArticleId><ArticleId IdType="pmc">PMC8476141</ArticleId><ArticleId IdType="pubmed">34115138</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggioli Mayara F, Lawson S, de Lima M, et al. Adaptive immune responses following Senecavirus a infection in pigs. J Virol. 2018;92(3):e01717. doi: 10.1128/JVI.01717-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01717-17</ArticleId><ArticleId IdType="pmc">PMC5774895</ArticleId><ArticleId IdType="pubmed">29142122</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Chu Z, Zhang M, et al. Molecular characterization of a novel clade echovirus 3 isolated from patients with hand-foot-and-mouth disease in southwest China. J Med Virol. 2023;95(11):e29202. doi: 10.1002/jmv.29202</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29202</ArticleId><ArticleId IdType="pubmed">37909741</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng T, Yang F, Yang F, et al. Structural diversity and biological role of the 5’ untranslated regions of picornavirus. RNA Biol. 2023;20(1):548–562. doi: 10.1080/15476286.2023.2240992</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2023.2240992</ArticleId><ArticleId IdType="pmc">PMC10402851</ArticleId><ArticleId IdType="pubmed">37534989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Ferrero DS, Verdaguer N, et al. Dual role of the foot-and-mouth disease virus 3B1 protein in the replication complex: as protein primer and as an essential component to recruit 3Dpol to membranes. PLoS Path. 2023;19(5):e1011373. doi: 10.1371/journal.ppat.1011373</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011373</ArticleId><ArticleId IdType="pmc">PMC10174528</ArticleId><ArticleId IdType="pubmed">37126532</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah Sahibzada W, Je W, Wang X, et al. Advances and breakthroughs in IRES-directed translation and replication of picornaviruses. MBio. 2023;14(2):e00358–23. doi: 10.1128/mbio.00358-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00358-23</ArticleId><ArticleId IdType="pmc">PMC10127998</ArticleId><ArticleId IdType="pubmed">36939331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Lu X, Zhao C, et al. Characterization of a novel picornavirus prevalent in experimental rabbits (Oryctolagus cuniculus). Heliyon. 2023;9(5):e15702. doi: 10.1016/j.heliyon.2023.e15702</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e15702</ArticleId><ArticleId IdType="pmc">PMC10163628</ArticleId><ArticleId IdType="pubmed">37159695</ArticleId></ArticleIdList></Reference><Reference><Citation>Linden LV, Wolthers KC, van Kuppeveld FJM.. Replication and inhibitors of enteroviruses and parechoviruses. Viruses. 2015;7(8):4529–4562. doi: 10.3390/v7082832</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082832</ArticleId><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson T, Belsham GJ. Picornaviruses: a view from 3A. Viruses. 2021;13(3):456. doi: 10.3390/v13030456</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030456</ArticleId><ArticleId IdType="pmc">PMC7999760</ArticleId><ArticleId IdType="pubmed">33799649</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul Aniko V, Rieder E, Kim Dong W, et al. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol. 2000;74(22):10359–10370. doi: 10.1128/JVI.74.22.10359-10370.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.22.10359-10370.2000</ArticleId><ArticleId IdType="pmc">PMC110910</ArticleId><ArticleId IdType="pubmed">11044080</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Rijnbrand R, McKnight Kevin L, et al. Sequence requirements for viral RNA replication and VPg uridylylation directed by the internal cis-acting replication element (cre) of human rhinovirus type 14. J Virol. 2002;76(15):7485–7494. doi: 10.1128/JVI.76.15.7485-7494.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.15.7485-7494.2002</ArticleId><ArticleId IdType="pmc">PMC136355</ArticleId><ArticleId IdType="pubmed">12097561</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagnola G, Weygandt M, Scoggin K, et al. Crystal structure of coxsackievirus B3 3Dpol highlights the functional importance of residue 5 in picornavirus polymerases. J Virol. 2008;82(19):9458–9464. doi: 10.1128/JVI.00647-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00647-08</ArticleId><ArticleId IdType="pmc">PMC2546958</ArticleId><ArticleId IdType="pubmed">18632862</ArticleId></ArticleIdList></Reference><Reference><Citation>Love RA, Maegley KA, Yu X, et al. The crystal structure of the RNA-dependent RNA polymerase from human rhinovirus: A dual function target for common cold antiviral therapy. Structure. 2004;12(8):1533–1544. doi: 10.1016/j.str.2004.05.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2004.05.024</ArticleId><ArticleId IdType="pubmed">15296746</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AA, Peersen OB. Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J. 2004;23(17):3462–3471. doi: 10.1038/sj.emboj.7600357</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600357</ArticleId><ArticleId IdType="pmc">PMC516629</ArticleId><ArticleId IdType="pubmed">15306852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Arias A, Perez-Luque R, et al. Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J Biol Chem. 2004;279(45):47212–47221. doi: 10.1074/jbc.M405465200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M405465200</ArticleId><ArticleId IdType="pubmed">15294895</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P, Peersen OB. Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc Natl Acad Sci USA. 2010;107(52):22505–22510. doi: 10.1073/pnas.1007626107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1007626107</ArticleId><ArticleId IdType="pmc">PMC3012486</ArticleId><ArticleId IdType="pubmed">21148772</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins CL, Kempf BJ, Beaucourt S, et al. Picornaviral polymerase domain exchanges reveal a modular basis for distinct biochemical activities of viral RNA-dependent RNA polymerases. J Biol Chem. 2020;295(31):10624–10637. doi: 10.1074/jbc.RA120.013906</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.013906</ArticleId><ArticleId IdType="pmc">PMC7397104</ArticleId><ArticleId IdType="pubmed">32493771</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Yin J, Mugavero J, et al. A “slide-back” mechanism for the initiation of protein-primed RNA synthesis by the RNA polymerase of poliovirus. J Biol Chem. 2003;278(45):43951–43960. doi: 10.1074/jbc.M307441200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M307441200</ArticleId><ArticleId IdType="pubmed">12937178</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, van Boom JH, Filippov D, et al. Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature. 1998;393(6682):280–284. doi: 10.1038/30529</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/30529</ArticleId><ArticleId IdType="pubmed">9607767</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul Aniko V, Peters J, Mugavero J, et al. Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J Virol. 2003;77(2):891–904. doi: 10.1128/JVI.77.2.891-904.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.2.891-904.2003</ArticleId><ArticleId IdType="pmc">PMC140777</ArticleId><ArticleId IdType="pubmed">12502805</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Z, Zhu J, Deng Y-N, et al. Sumoylation modification-mediated cell death. Open Biol. 2021;11(7):210050. doi: 10.1098/rsob.210050</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.210050</ArticleId><ArticleId IdType="pmc">PMC8277462</ArticleId><ArticleId IdType="pubmed">34255975</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Qiu C, Wang Y, et al. FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis. Proc Natl Acad Sci U S A. 2022;119(26):e2202631119. doi: 10.1073/pnas.2202631119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2202631119</ArticleId><ArticleId IdType="pmc">PMC9245619</ArticleId><ArticleId IdType="pubmed">35733256</ArticleId></ArticleIdList></Reference><Reference><Citation>Buschmann T, Fuchs SY, Lee C-G, et al. Sumo-1 modification of mdm2 prevents its self-ubiquitination and increases mdm2 ability to ubiquitinate p53. Cell. 2000;101(7):753–762. doi: 10.1016/S0092-8674(00)80887-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80887-9</ArticleId><ArticleId IdType="pubmed">10892746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernier-Villamor V, Sampson DA, Matunis MJ, et al. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell. 2002;108(3):345–356. doi: 10.1016/S0092-8674(02)00630-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00630-X</ArticleId><ArticleId IdType="pubmed">11853669</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zheng Z, Shu B, et al. SUMO modification stabilizes enterovirus 71 polymerase 3D to facilitate viral replication. J Virol. 2016;90(23):10472–10485. doi: 10.1128/JVI.01756-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01756-16</ArticleId><ArticleId IdType="pmc">PMC5110190</ArticleId><ArticleId IdType="pubmed">27630238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao H, Hao S, Chen H, et al. N6-methyladenosine modification and METTL3 modulate enterovirus 71 replication. Nucleic Acids Res. 2019;47(1):362–374. doi: 10.1093/nar/gky1007</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1007</ArticleId><ArticleId IdType="pmc">PMC6326802</ArticleId><ArticleId IdType="pubmed">30364964</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai S-I, Armstrong CM, Kaeberlein M, et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403(6771):795–800. doi: 10.1038/35001622</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35001622</ArticleId><ArticleId IdType="pubmed">10693811</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Liu H, Ren X, et al. Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation. Oncogene. 2022;41(39):4474–4484. doi: 10.1038/s41388-022-02447-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-022-02447-y</ArticleId><ArticleId IdType="pubmed">36030331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Li Y, Zhang Y, et al. SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1. Cardiovasc Diabetol. 2023;22(1):331. doi: 10.1186/s12933-023-02040-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-02040-x</ArticleId><ArticleId IdType="pmc">PMC10685714</ArticleId><ArticleId IdType="pubmed">38017499</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Wang L, Cui J, et al. SIRT1 inhibits EV71 genome replication and RNA translation by interfering with the viral polymerase and 5‘UTR RNA. J Cell Sci. 2016;129(24):4534–4547. doi: 10.1242/jcs.193698</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.193698</ArticleId><ArticleId IdType="pmc">PMC5201017</ArticleId><ArticleId IdType="pubmed">27875274</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-C, Kuo R-L, Lin J-Y, et al. Cytoplasmic viral RNA-dependent RNA polymerase disrupts the intracellular splicing machinery by entering the nucleus and interfering with Prp8. PLoS Path. 2014;10(6):e1004199. doi: 10.1371/journal.ppat.1004199</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004199</ArticleId><ArticleId IdType="pmc">PMC4072778</ArticleId><ArticleId IdType="pubmed">24968230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K-M, Wu C-C, Wu S-E, et al. The RNA-dependent RNA polymerase of enterovirus A71 associates with ribosomal proteins and positively regulates protein translation. RNA Biol. 2020;17(4):608–622. doi: 10.1080/15476286.2020.1722448</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1722448</ArticleId><ArticleId IdType="pmc">PMC7237135</ArticleId><ArticleId IdType="pubmed">32009553</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar HM, Dorobantu CM, Albulescu L, et al. Fat(al) attraction: picornaviruses usurp lipid transfer at membrane contact sites to create replication organelles. Trends Microbiol. 2016;24(7):535–546. doi: 10.1016/j.tim.2016.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.02.017</ArticleId><ArticleId IdType="pmc">PMC7126954</ArticleId><ArticleId IdType="pubmed">27020598</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, van Kuppeveld FJM. (+)RNA viruses rewire cellular pathways to build replication organelles. Curr Opin Virol. 2012;2(6):740–747. doi: 10.1016/j.coviro.2012.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.09.006</ArticleId><ArticleId IdType="pmc">PMC7102821</ArticleId><ArticleId IdType="pubmed">23036609</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X, Lei X, Zhang Z, et al. Enterovirus 3A facilitates viral replication by promoting phosphatidylinositol 4-kinase IIIβ-ACBD3 interaction. J Virol. 2017;91(19):e00791–17. doi: 10.1128/JVI.00791-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00791-17</ArticleId><ArticleId IdType="pmc">PMC5599760</ArticleId><ArticleId IdType="pubmed">28701404</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger Alexander L, Knudsen Giselle M, Betegon M, et al. The 3A protein from multiple picornaviruses utilizes the golgi adaptor protein ACBD3 to recruit PI4KIIIβ. J Virol. 2012;86(7):3605–3616. doi: 10.1128/JVI.06778-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06778-11</ArticleId><ArticleId IdType="pmc">PMC3302542</ArticleId><ArticleId IdType="pubmed">22258260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu N-Y, Ilnytska O, Belov G, et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 2010;141(5):799–811. doi: 10.1016/j.cell.2010.03.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.050</ArticleId><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Li S, Lei P, et al. ANXA2 facilitates enterovirus 71 infection by interacting with 3D polymerase and PI4KB to assist the assembly of replication organelles. Virol Sin. 2021;36(6):1387–1399. doi: 10.1007/s12250-021-00417-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-021-00417-4</ArticleId><ArticleId IdType="pmc">PMC8692544</ArticleId><ArticleId IdType="pubmed">34196914</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Z, Wang L, Deng W, et al. Structural insight into the Ragulator complex which anchors mTORC1 to the lysosomal membrane. Cell Discov. 2017;3(1):17049. doi: 10.1038/celldisc.2017.49</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/celldisc.2017.49</ArticleId><ArticleId IdType="pmc">PMC5742854</ArticleId><ArticleId IdType="pubmed">29285400</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M-Y, Morris KL, Kim DJ, et al. Hybrid structure of the RagA/C-Ragulator mTORC1 activation complex. Mol Cell. 2017;68(5):835–846.e3. doi: 10.1016/j.molcel.2017.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.10.016</ArticleId><ArticleId IdType="pmc">PMC5722659</ArticleId><ArticleId IdType="pubmed">29107538</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Hu Z, Zhang W, et al. Inhibition of lysosome-tethered ragulator-rag-3D complex restricts the replication of enterovirus 71 and coxsackie A16. J Cell Bio. 2023;222(12):e202303108. doi: 10.1083/jcb.202303108</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202303108</ArticleId><ArticleId IdType="pmc">PMC10619577</ArticleId><ArticleId IdType="pubmed">37906052</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P-N, Jheng J-R, Arnold JJ, et al. UGGT1 enhances enterovirus 71 pathogenicity by promoting viral RNA synthesis and viral replication. PLoS Path. 2017;13(5):e1006375. doi: 10.1371/journal.ppat.1006375</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006375</ArticleId><ArticleId IdType="pmc">PMC5435352</ArticleId><ArticleId IdType="pubmed">28545059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning Z, Zhong X, Wu Y, et al. β-asarone improves cognitive impairment and alleviates autophagy in mice with vascular dementia via the cAMP/PKA/CREB pathway. Phytomedicine. 2023;123:155215. doi: 10.1016/j.phymed.2023.155215</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2023.155215</ArticleId><ArticleId IdType="pubmed">38039902</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Kong L, Oliver BA, et al. Constitutively active autophagy in macrophages dampens inflammation through metabolic and post-transcriptional regulation of cytokine production. Cell Rep. 2023;42(7):112708. doi: 10.1016/j.celrep.2023.112708</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112708</ArticleId><ArticleId IdType="pmc">PMC10503440</ArticleId><ArticleId IdType="pubmed">37392388</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Q, Wan P, Yang G, et al. Beclin1 binds to enterovirus 71 3D protein to promote the virus replication. Viruses. 2020;12(7):756. doi: 10.3390/v12070756</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12070756</ArticleId><ArticleId IdType="pmc">PMC7411969</ArticleId><ArticleId IdType="pubmed">32674313</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Xu W, Chen D, et al. Enterovirus 71 induces autophagy by regulating has-miR-30a expression to promote viral replication. Antiviral Res. 2015;124:43–53. doi: 10.1016/j.antiviral.2015.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.09.016</ArticleId><ArticleId IdType="pubmed">26515789</ArticleId></ArticleIdList></Reference><Reference><Citation>Abernathy E, Mateo R, Majzoub K, et al. Differential and convergent utilization of autophagy components by positive-strand RNA viruses. PLoS Biol. 2019;17(1):e2006926. doi: 10.1371/journal.pbio.2006926</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2006926</ArticleId><ArticleId IdType="pmc">PMC6334974</ArticleId><ArticleId IdType="pubmed">30608919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y, Wang QJ, Li X, et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with beclin 1-phosphatidylinositol-3-kinase complex. Nat Cell Biol. 2009;11(4):468–476. doi: 10.1038/ncb1854</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1854</ArticleId><ArticleId IdType="pmc">PMC2664389</ArticleId><ArticleId IdType="pubmed">19270693</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wang K, Xing Y, et al. Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity. Protein Cell. 2014;5(12):912–927. doi: 10.1007/s13238-014-0104-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0104-6</ArticleId><ArticleId IdType="pmc">PMC4259884</ArticleId><ArticleId IdType="pubmed">25311841</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo DS, Park NY, Cho D-H. Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases. Exp Mol Med. 2020;52(9):1486–1495. doi: 10.1038/s12276-020-00503-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00503-9</ArticleId><ArticleId IdType="pmc">PMC8080768</ArticleId><ArticleId IdType="pubmed">32917959</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lu W, Shi B, et al. Peroxisomal regulation of redox homeostasis and adipocyte metabolism. Redox Biol. 2019;24:101167. doi: 10.1016/j.redox.2019.101167</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101167</ArticleId><ArticleId IdType="pmc">PMC6434164</ArticleId><ArticleId IdType="pubmed">30921635</ArticleId></ArticleIdList></Reference><Reference><Citation>You L, Chen J, Liu W, et al. Enterovirus 71 induces neural cell apoptosis and autophagy through promoting ACOX1 downregulation and ROS generation. Virulence. 2020;11(1):537–553. doi: 10.1080/21505594.2020.1766790</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2020.1766790</ArticleId><ArticleId IdType="pmc">PMC7250321</ArticleId><ArticleId IdType="pubmed">32434419</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27(1):229–265. doi: 10.1146/annurev.immunol.021908.132715</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132715</ArticleId><ArticleId IdType="pubmed">19302040</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801. doi: 10.1016/j.cell.2006.02.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.015</ArticleId><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Sastre A. Ten Strategies of interferon evasion by viruses. Cell Host Microbe. 2017;22(2):176–184. doi: 10.1016/j.chom.2017.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.07.012</ArticleId><ArticleId IdType="pmc">PMC5576560</ArticleId><ArticleId IdType="pubmed">28799903</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Xiao F, Wan P, et al. EV71 3D protein binds with NLRP3 and enhances the assembly of inflammasome complex. PLoS Path. 2017;13(1):e1006123. doi: 10.1371/journal.ppat.1006123</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006123</ArticleId><ArticleId IdType="pmc">PMC5245909</ArticleId><ArticleId IdType="pubmed">28060938</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Lee J-H, Parker ZM, et al. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity. Nat Microbiol. 2021;6(4):467–478. doi: 10.1038/s41564-021-00884-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00884-1</ArticleId><ArticleId IdType="pmc">PMC8103894</ArticleId><ArticleId IdType="pubmed">33727702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441(7089):101–105. doi: 10.1038/nature04734</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R-L, Chen C-J, Wang Robert YL, et al. Role of enteroviral RNA-dependent RNA polymerase in regulation of MDA5-mediated beta interferon activation. J Virol. 2019;93(10):e00132–19. doi: 10.1128/JVI.00132-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00132-19</ArticleId><ArticleId IdType="pmc">PMC6498057</ArticleId><ArticleId IdType="pubmed">30814289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Zheng H, Li H, et al. The expression of IFN-β is suppressed by the viral 3D polymerase via its impact on PGAM5 expression during enterovirus D68 infection. Virus Res. 2021;304:198549. doi: 10.1016/j.virusres.2021.198549</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2021.198549</ArticleId><ArticleId IdType="pubmed">34425164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C, Qin X, Tan Y, et al. SHFL inhibits enterovirus A71 infection by triggering degradation of viral 3Dpol protein via the ubiquitin–proteasome pathway. J Med Virol. 2023;95(8):e29030. doi: 10.1002/jmv.29030</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29030</ArticleId><ArticleId IdType="pubmed">37565734</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Bai J, Fan H, et al. E2 ubiquitin-conjugating enzyme UBE2L6 promotes senecavirus a proliferation by stabilizing the viral RNA polymerase. PLoS Path. 2020;16(10):e1008970. doi: 10.1371/journal.ppat.1008970</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008970</ArticleId><ArticleId IdType="pmc">PMC7588118</ArticleId><ArticleId IdType="pubmed">33104725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence P, Schafer EA, Rieder E. The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells. Virology. 2012;425(1):40–52. doi: 10.1016/j.virol.2011.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.12.019</ArticleId><ArticleId IdType="pubmed">22280896</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh K, Soros V, Cochrane A. Selective translational repression of HIV-1 RNA by Sam68DeltaC occurs by altering PABP1 binding to unspliced viral RNA. Retrovirology. 2008;5(1):97. doi: 10.1186/1742-4690-5-97</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-5-97</ArticleId><ArticleId IdType="pmc">PMC2584037</ArticleId><ArticleId IdType="pubmed">18957126</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride AE, Schlegel A, Kirkegaard K. Human protein Sam68 relocalization and interaction with poliovirus RNA polymerase in infected cells. Proc Natl Acad Sci U S A. 1996;93(6):2296–2301. doi: 10.1073/pnas.93.6.2296</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.6.2296</ArticleId><ArticleId IdType="pmc">PMC39789</ArticleId><ArticleId IdType="pubmed">8637866</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai DK, Lawrence P, Kloc A, et al. Analysis of the interaction between host factor Sam68 and viral elements during foot-and-mouth disease virus infections. Virol J. 2015;12(1):224. doi: 10.1186/s12985-015-0452-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0452-8</ArticleId><ArticleId IdType="pmc">PMC4689063</ArticleId><ArticleId IdType="pubmed">26695943</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury SM, Ma X, Zeng Z, et al. Senecavirus a 3D interacts with NLRP3 to induce IL-1β production by activating NF-κB and ion channel signals. Microbiol Spectr. 2022;10(2):e02097–21. doi: 10.1128/spectrum.02097-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02097-21</ArticleId><ArticleId IdType="pmc">PMC9045273</ArticleId><ArticleId IdType="pubmed">35254168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Wu W, Xie L, et al. Cellular RNA helicase DDX1 is involved in transmissible gastroenteritis virus nsp14-induced interferon-beta production. Front Immunol. 2017;8. doi: 10.3389/fimmu.2017.00940</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00940</ArticleId><ArticleId IdType="pmc">PMC5552718</ArticleId><ArticleId IdType="pubmed">28848548</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgcomb SP, Carmel AB, Naji S, et al. DDX1 is an RNA-dependent ATPase involved in HIV-1 rev function and virus replication. J Mol Biol. 2012;415(1):61–74. doi: 10.1016/j.jmb.2011.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.10.032</ArticleId><ArticleId IdType="pmc">PMC3249508</ArticleId><ArticleId IdType="pubmed">22051512</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Q, Liu H, Zeng Q, et al. The DEAD-Box RNA helicase DDX1 interacts with the viral protein 3D and inhibits foot-and-mouth disease virus replication. Virol Sin. 2019;34(6):610–617. doi: 10.1007/s12250-019-00148-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00148-7</ArticleId><ArticleId IdType="pmc">PMC6888807</ArticleId><ArticleId IdType="pubmed">31359346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarry M, Caignard G, Dupré J, et al. Host-specific interplay between foot-and-mouth disease virus 3D polymerase and the type-I interferon pathway. Viruses. 2023;15(3):666. doi: 10.3390/v15030666</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030666</ArticleId><ArticleId IdType="pmc">PMC10054395</ArticleId><ArticleId IdType="pubmed">36992375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Hu Y, Zheng M. Enterovirus A71 antivirals: past, present, and future. Acta Pharm Sin B. 2022;12(4):1542–1566. doi: 10.1016/j.apsb.2021.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.08.017</ArticleId><ArticleId IdType="pmc">PMC9279511</ArticleId><ArticleId IdType="pubmed">35847514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Musharrafieh R, Zheng M, et al. Enterovirus D68 antivirals: past, present, and future. ACS Infect Dis. 2020;6(7):1572–1586. doi: 10.1021/acsinfecdis.0c00120</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00120</ArticleId><ArticleId IdType="pmc">PMC8055446</ArticleId><ArticleId IdType="pubmed">32352280</ArticleId></ArticleIdList></Reference><Reference><Citation>Laajala M, Reshamwala D, Marjomäki V. Therapeutic targets for enterovirus infections. Expert Opin Ther Targets. 2020;24(8):745–757. doi: 10.1080/14728222.2020.1784141</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2020.1784141</ArticleId><ArticleId IdType="pubmed">32552314</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C, Tian L, Liu Y, et al. A promising antiviral candidate drug for the COVID-19 pandemic: a mini-review of remdesivir. Eur J Med Chem. 2020;201:112527. doi: 10.1016/j.ejmech.2020.112527</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112527</ArticleId><ArticleId IdType="pmc">PMC7834743</ArticleId><ArticleId IdType="pubmed">32563812</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Grande R, Jiménez-Pérez M, González Arjona C, et al. New approaches in the treatment of hepatitis C. World J Gastroenterol. 2016;22(4):1421–1432. doi: 10.3748/wjg.v22.i4.1421</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v22.i4.1421</ArticleId><ArticleId IdType="pmc">PMC4721977</ArticleId><ArticleId IdType="pubmed">26819511</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Maag D, Arnold JJ, et al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med. 2000;6(12):1375–1379. doi: 10.1038/82191</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/82191</ArticleId><ArticleId IdType="pubmed">11100123</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikunjkumar P, Tamil Selvan RP, Bhanuprakash V. Ribavirin as a curative and prophylactic agent against foot and mouth disease virus infection in C57BL/6 suckling and adult mice model. Virusdisease. 2021;32(4):737–747. doi: 10.1007/s13337-021-00746-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00746-8</ArticleId><ArticleId IdType="pmc">PMC8630122</ArticleId><ArticleId IdType="pubmed">34901324</ArticleId></ArticleIdList></Reference><Reference><Citation>Graci Jason D, Harki Daniel A, Korneeva Victoria S, et al. Lethal mutagenesis of poliovirus mediated by a mutagenic pyrimidine analogue. J Virol. 2007;81(20):11256–11266. doi: 10.1128/JVI.01028-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01028-07</ArticleId><ArticleId IdType="pmc">PMC2045539</ArticleId><ArticleId IdType="pubmed">17686844</ArticleId></ArticleIdList></Reference><Reference><Citation>Graci JD, Too K, Smidansky ED, et al. Lethal mutagenesis of picornaviruses with N-6-modified purine nucleoside analogues. Antimicrob Agents Chemother. 2008;52(3):971–979. doi: 10.1128/AAC.01056-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01056-07</ArticleId><ArticleId IdType="pmc">PMC2258490</ArticleId><ArticleId IdType="pubmed">18180344</ArticleId></ArticleIdList></Reference><Reference><Citation>Harki DA, Graci JD, Galarraga JE, et al. Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases. J Med Chem. 2006;49(21):6166–6169. doi: 10.1021/jm060872x</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm060872x</ArticleId><ArticleId IdType="pmc">PMC2094219</ArticleId><ArticleId IdType="pubmed">17034123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z, Chen Y-L, Schul W, et al. An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A. 2009;106(48):20435–20439. doi: 10.1073/pnas.0907010106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0907010106</ArticleId><ArticleId IdType="pmc">PMC2787148</ArticleId><ArticleId IdType="pubmed">19918064</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng C-L, Yeo H, Ye H-Q, et al. Inhibition of enterovirus 71 by adenosine analog NITD008. J Virol. 2014;88(20):11915–11923. doi: 10.1128/JVI.01207-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01207-14</ArticleId><ArticleId IdType="pmc">PMC4178731</ArticleId><ArticleId IdType="pubmed">25100827</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Wang Y, Qing J, et al. An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation. Antiviral Res. 2014;112:47–58. doi: 10.1016/j.antiviral.2014.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.10.009</ArticleId><ArticleId IdType="pubmed">25446894</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, Cao R, Zhang H, et al. Design, synthesis and evaluation of 2’-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents. Eur J Med Chem. 2021;226:113852. doi: 10.1016/j.ejmech.2021.113852</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2021.113852</ArticleId><ArticleId IdType="pubmed">34560428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Yang E, Hu C, et al. Cell-based high-throughput screening assay identifies 2‘,2’-difluoro-2’-deoxycytidine gemcitabine as a potential antipoliovirus agent. ACS Infect Dis. 2017;3(1):45–53. doi: 10.1021/acsinfecdis.6b00116</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.6b00116</ArticleId><ArticleId IdType="pmc">PMC5754216</ArticleId><ArticleId IdType="pubmed">27733043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L, Wang Q, Yang X, et al. Antiviral activity of Fnc, 2’-deoxy-2’-β-fluoro-4’-azidocytidine, against human and duck HBV replication. Antivir Ther. 2012;17(4):679–687. doi: 10.3851/IMP2094</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP2094</ArticleId><ArticleId IdType="pubmed">22452880</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R-R, Yang Q-H, Luo R-H, et al. Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. PLoS One. 2014;9(8):e105617. doi: 10.1371/journal.pone.0105617</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105617</ArticleId><ArticleId IdType="pmc">PMC4140803</ArticleId><ArticleId IdType="pubmed">25144636</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu N, Yang J, Zheng B, et al. The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses. J Virol. 2020;94(9):e00204–20. doi: 10.1128/JVI.00204-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00204-20</ArticleId><ArticleId IdType="pmc">PMC7163137</ArticleId><ArticleId IdType="pubmed">32075935</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AJ, Won JJ, Graham RL, et al. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res. 2019;169:104541. doi: 10.1016/j.antiviral.2019.104541</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.104541</ArticleId><ArticleId IdType="pmc">PMC6699884</ArticleId><ArticleId IdType="pubmed">31233808</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren TK, Jordan R, Lo MK, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531(7594):381–385. doi: 10.1038/nature17180</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17180</ArticleId><ArticleId IdType="pmc">PMC5551389</ArticleId><ArticleId IdType="pubmed">26934220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye W, Yao M, Dong Y, et al. Remdesivir (GS-5734) impedes enterovirus replication through viral RNA synthesis inhibition. Front Microbiol. 2020;11:1105. doi: 10.3389/fmicb.2020.01105</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01105</ArticleId><ArticleId IdType="pmc">PMC7304253</ArticleId><ArticleId IdType="pubmed">32595613</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermingham WH, Canning B, Wilton T, et al. Case report: clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection. Front Immunol. 2023;14:1135834. doi: 10.3389/fimmu.2023.1135834</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1135834</ArticleId><ArticleId IdType="pmc">PMC10022663</ArticleId><ArticleId IdType="pubmed">36936936</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi T, Fukai K, Masujin K, et al. Administration of the antiviral agent T-1105 fully protects pigs from foot-and-mouth disease infection. Antiviral Res. 2022;208:105425. doi: 10.1016/j.antiviral.2022.105425</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105425</ArticleId><ArticleId IdType="pubmed">36181971</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta Y, Gowen BB, Takahashi K, et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013;100(2):446–454. doi: 10.1016/j.antiviral.2013.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.09.015</ArticleId><ArticleId IdType="pmc">PMC3880838</ArticleId><ArticleId IdType="pubmed">24084488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumby CK, Zhao L, Oporto M, et al. Favipiravir and zanamivir cleared infection with influenza B in a severely immunocompromised child. Clin Infect Dis. 2020;71(7):e191–e194. doi: 10.1093/cid/ciaa023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa023</ArticleId><ArticleId IdType="pubmed">32124919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki-Tanaka R, Shibata T, Okamoto H, et al. Favipiravir inhibits hepatitis a virus infection in human hepatocytes. Int J Mol Sci. 2022;23(5):2631. doi: 10.3390/ijms23052631</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052631</ArticleId><ArticleId IdType="pmc">PMC8910232</ArticleId><ArticleId IdType="pubmed">35269774</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempf Brian J, Watkins Colleen L, Peersen Olve B, et al. Picornavirus RNA recombination counteracts error catastrophe. J Virol. 2019;93(14):e00652–19. doi: 10.1128/JVI.00652-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00652-19</ArticleId><ArticleId IdType="pmc">PMC6600191</ArticleId><ArticleId IdType="pubmed">31068422</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra S, Dávila M, Lowenstein PR, et al. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol. 2000;74(18):8316–8323. doi: 10.1128/JVI.74.18.8316-8323.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.18.8316-8323.2000</ArticleId><ArticleId IdType="pmc">PMC116341</ArticleId><ArticleId IdType="pubmed">10954530</ArticleId></ArticleIdList></Reference><Reference><Citation>Pariente N, Airaksinen A, Domingo E. Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J Virol. 2003;77(12):7131–7138. doi: 10.1128/JVI.77.12.7131-7138.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.12.7131-7138.2003</ArticleId><ArticleId IdType="pmc">PMC156209</ArticleId><ArticleId IdType="pubmed">12768034</ArticleId></ArticleIdList></Reference><Reference><Citation>Agudo R, Arias A, Pariente N, et al. Molecular characterization of a dual inhibitory and mutagenic activity of 5-fluorouridine triphosphate on viral RNA synthesis. Implications for lethal mutagenesis. J Mol Biol. 2008;382(3):652–666. doi: 10.1016/j.jmb.2008.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2008.07.033</ArticleId><ArticleId IdType="pubmed">18662697</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhat A, Malecki E, Bonaterra GA, et al. Cytostatic/cytotoxic effects of 5-fluorouridine nucleolipids on colon, hepatocellular, and renal carcinoma cells: In vitro identification of a potential cytotoxic multi-anticancer drug. Chem Biodivers. 2014;11(3):469–482. doi: 10.1002/cbdv.201300347</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbdv.201300347</ArticleId><ArticleId IdType="pubmed">24634076</ArticleId></ArticleIdList></Reference><Reference><Citation>Graci JD, Cameron CE. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006;16(1):37–48. doi: 10.1002/rmv.483</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.483</ArticleId><ArticleId IdType="pmc">PMC7169142</ArticleId><ArticleId IdType="pubmed">16287208</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Torre JC, Alarcón B, Martínez-Salas E, et al. Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro. J Virol. 1987;61(1):233–235. doi: 10.1128/jvi.61.1.233-235.1987</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.61.1.233-235.1987</ArticleId><ArticleId IdType="pmc">PMC255252</ArticleId><ArticleId IdType="pubmed">3023704</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JH, Jeong K, Kim SM, et al. Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease. J Vet Sci. 2018;19(6):788–797. doi: 10.4142/jvs.2018.19.6.788</Citation><ArticleIdList><ArticleId IdType="doi">10.4142/jvs.2018.19.6.788</ArticleId><ArticleId IdType="pmc">PMC6265586</ArticleId><ArticleId IdType="pubmed">30304889</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Cameron CE, Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A. 2001;98(12):6895–6900. doi: 10.1073/pnas.111085598</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.111085598</ArticleId><ArticleId IdType="pmc">PMC34449</ArticleId><ArticleId IdType="pubmed">11371613</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignuzzi M, Stone JK, Andino R. Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res. 2005;107(2):173–181. doi: 10.1016/j.virusres.2004.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2004.11.007</ArticleId><ArticleId IdType="pubmed">15649563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Smidansky ED, Oh HS, et al. Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses. J Med Chem. 2010;53(22):7958–7966. doi: 10.1021/jm100593s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm100593s</ArticleId><ArticleId IdType="pmc">PMC2990348</ArticleId><ArticleId IdType="pubmed">20964406</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll SS, Tomassini JE, Bosserman M, et al. Inhibition of hepatitis C virus RNA replication by 2’-modified nucleoside analogs. J Biol Chem. 2003;278(14):11979–11984. doi: 10.1074/jbc.M210914200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M210914200</ArticleId><ArticleId IdType="pubmed">12554735</ArticleId></ArticleIdList></Reference><Reference><Citation>Goris N, De Palma A, Toussaint J-F, et al. 2’-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus. Antiviral Res. 2007;73(3):161–168. doi: 10.1016/j.antiviral.2006.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2006.09.007</ArticleId><ArticleId IdType="pubmed">17055073</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanko K, Ma Y, Delang L, et al. Antiviral effects of selected nucleoside analogues against human parechoviruses A1 and A3. Antiviral Res. 2019;162:51–53. doi: 10.1016/j.antiviral.2018.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.12.009</ArticleId><ArticleId IdType="pubmed">30550798</ArticleId></ArticleIdList></Reference><Reference><Citation>Masmoudi F, Santos-Ferreira N, Pajkrt D, et al. Evaluation of 3D human intestinal organoids as a platform for EV-A71 antiviral drug discovery. Cells. 2023;12(8):1138. doi: 10.3390/cells12081138</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12081138</ArticleId><ArticleId IdType="pmc">PMC10136548</ArticleId><ArticleId IdType="pubmed">37190047</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison DN, Gazina EV, Purcell DF, et al. Amiloride derivatives inhibit coxsackievirus B3 RNA replication. J Virol. 2008;82(3):1465–1473. doi: 10.1128/JVI.01374-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01374-07</ArticleId><ArticleId IdType="pmc">PMC2224459</ArticleId><ArticleId IdType="pubmed">18032495</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazina EV, Smidansky ED, Holien JK, et al. Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase. J Virol. 2011;85(19):10364–10374. doi: 10.1128/JVI.05022-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05022-11</ArticleId><ArticleId IdType="pmc">PMC3196452</ArticleId><ArticleId IdType="pubmed">21795353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogram SA, Boone CD, McKenna R, et al. Amiloride inhibits the initiation of coxsackievirus and poliovirus RNA replication by inhibiting VPg uridylylation. Virology. 2014;464-465:87–97. doi: 10.1016/j.virol.2014.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2014.06.025</ArticleId><ArticleId IdType="pmc">PMC4542153</ArticleId><ArticleId IdType="pubmed">25058507</ArticleId></ArticleIdList></Reference><Reference><Citation>Holien JK, Gazina EV, Elliott RW, et al. Computational analysis of amiloride analogue inhibitors of coxsackievirus B3 RNA polymerase. J Proteomics Bioinform. 2014;s9(Suppl 9):004. doi: 10.4172/jpb.S9-004</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/jpb.S9-004</ArticleId><ArticleId IdType="pmc">PMC4610404</ArticleId><ArticleId IdType="pubmed">26491236</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi LI, Gnädig NF, Beaucourt S, et al. Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLoS Path. 2010;6(10):e1001163. doi: 10.1371/journal.ppat.1001163</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001163</ArticleId><ArticleId IdType="pmc">PMC2965762</ArticleId><ArticleId IdType="pubmed">21060812</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong M-J, Chang Y-Y, Shao J, et al. Antiviral effect of amiloride on replication of foot and mouth disease virus in cell culture. Microbial Pathogenesis. 2019;135:103638. doi: 10.1016/j.micpath.2019.103638</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2019.103638</ArticleId><ArticleId IdType="pmc">PMC7125800</ArticleId><ArticleId IdType="pubmed">31326561</ArticleId></ArticleIdList></Reference><Reference><Citation>Chern J-H, Shia K-S, Hsu T-A, et al. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors. Bioorg Med Chem Lett. 2004;14(10):2519–2525. doi: 10.1016/j.bmcl.2004.02.092</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2004.02.092</ArticleId><ArticleId IdType="pubmed">15109643</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T-C, Chang H-Y, Lin P-F, et al. Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrob Agents Chemother. 2009;53(7):2740–2747. doi: 10.1128/AAC.00101-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00101-09</ArticleId><ArticleId IdType="pmc">PMC2704669</ArticleId><ArticleId IdType="pubmed">19414569</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H-C, Chen T-C, Fang M-Y, et al. Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chemother. 2010;65(4):676–683. doi: 10.1093/jac/dkp502</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkp502</ArticleId><ArticleId IdType="pmc">PMC7110181</ArticleId><ArticleId IdType="pubmed">20089540</ArticleId></ArticleIdList></Reference><Reference><Citation>Durk RC, Singh K, Cornelison CA, et al. Inhibitors of foot and mouth disease virus targeting a novel pocket of the RNA-dependent RNA polymerase. PloS One. 2010;5(12):e15049. doi: 10.1371/journal.pone.0015049</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015049</ArticleId><ArticleId IdType="pmc">PMC3006429</ArticleId><ArticleId IdType="pubmed">21203539</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai DK, Schafer EA, Singh K, et al. Repeated exposure to 5D9, an inhibitor of 3D polymerase, effectively limits the replication of foot-and-mouth disease virus in host cells. Antiviral Res. 2013;98(3):380–385. doi: 10.1016/j.antiviral.2013.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.03.022</ArticleId><ArticleId IdType="pmc">PMC4141565</ArticleId><ArticleId IdType="pubmed">23578728</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden L, Vives-Adrián L, Selisko B, et al. The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family. PloS Path. 2015;11(3):e1004733. doi: 10.1371/journal.ppat.1004733</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004733</ArticleId><ArticleId IdType="pmc">PMC4370873</ArticleId><ArticleId IdType="pubmed">25799064</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Wang M, Chen Y, et al. Structure of the enterovirus D68 RNA-dependent RNA polymerase in complex with NADPH implicates an inhibitor binding site in the RNA template tunnel. J Struct Biol. 2020;211(1):107510. doi: 10.1016/j.jsb.2020.107510</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2020.107510</ArticleId><ArticleId IdType="pubmed">32353513</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagnola G, Gong P, Peersen OB. High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. Antiviral Res. 2011;91(3):241–251. doi: 10.1016/j.antiviral.2011.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.06.006</ArticleId><ArticleId IdType="pmc">PMC3159743</ArticleId><ArticleId IdType="pubmed">21722674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J-A, Yeh J-Y, Lin T-J, et al. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus. Antimicrob Agents Chemother. 2012;56(2):647–657. doi: 10.1128/AAC.00125-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00125-11</ArticleId><ArticleId IdType="pmc">PMC3264257</ArticleId><ArticleId IdType="pubmed">21930871</ArticleId></ArticleIdList></Reference><Reference><Citation>Velu AB, Chen G-W, Hsieh P-T, et al. BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of enterovirus 71. Antiviral Res. 2014;112:18–25. doi: 10.1016/j.antiviral.2014.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.10.003</ArticleId><ArticleId IdType="pubmed">25448086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074–D1082. doi: 10.1093/nar/gkx1037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1037</ArticleId><ArticleId IdType="pmc">PMC5753335</ArticleId><ArticleId IdType="pubmed">29126136</ArticleId></ArticleIdList></Reference><Reference><Citation>Theerawatanasirikul S, Lueangaramkul V, Semkum P, et al. Antiviral mechanisms of sorafenib against foot-and-mouth disease virus via c-RAF and AKT/PI3K pathways. Vet Res Commun. 2023;48(1):329–343. doi: 10.1007/s11259-023-10211-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11259-023-10211-0</ArticleId><ArticleId IdType="pubmed">37697209</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Xu Z, Liang J, et al. Identification of a novel acylthiourea-based potent broad-spectrum inhibitor for enterovirus 3D polymerase in vitro and in vivo. Antiviral Res. 2023;213:105583. doi: 10.1016/j.antiviral.2023.105583</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2023.105583</ArticleId><ArticleId IdType="pubmed">36965527</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong K-W, Lee J-H, Park S-M, et al. Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD). European Journal Of Medicinal Chemistry. 2015;102:387–397. doi: 10.1016/j.ejmech.2015.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2015.08.020</ArticleId><ArticleId IdType="pubmed">26301555</ArticleId></ArticleIdList></Reference><Reference><Citation>Theerawatanasirikul S, Semkum P, Lueangaramkul V, et al. Non-nucleoside inhibitors decrease foot-and-mouth disease virus replication by blocking the viral 3Dpol. Viruses. 2023;15(1):124. doi: 10.3390/v15010124</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010124</ArticleId><ArticleId IdType="pmc">PMC9866314</ArticleId><ArticleId IdType="pubmed">36680163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanko K, Shi C, Patil S, et al. Assessing in vitro resistance development in enterovirus A71 in the context of combination antiviral treatment. ACS Infect Dis. 2021;7(10):2801–2806. doi: 10.1021/acsinfecdis.0c00872</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00872</ArticleId><ArticleId IdType="pubmed">34529400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Q, Sun W, Wang C, et al. Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev. 2016;98:19–34. doi: 10.1016/j.addr.2015.10.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2015.10.022</ArticleId><ArticleId IdType="pmc">PMC4998845</ArticleId><ArticleId IdType="pubmed">26546751</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>